Founded in 1998,Alfred E. Mann Institute forBiomedical Engineering at theUniversity of Southern California (AMI-USC) was a501c(3)non-profit organization[1] dedicated to biomedical[2] engineeringtechnology development. The institute was located on theUniversity Park Campus of USC inLos Angeles, California and focuses on helping to bridge the gap betweendiscovery research and product commercialization.[3] As of 2022, the institute'sfinancial endowment was $230 million, with over $150 million[4] donated bymedical deviceentrepreneur andphilanthropist Alfred E. Mann.[5]
In 2015, a former employee of AMI-USC filed a lawsuit against the institute, USC, and two of AMI-USC's executives. The plaintiff accused the institute ofsexual harassment andwrongful termination. The plaintiff was represented by The Bloom Firm, led by attorneyLisa Bloom. The case was settled via arbitration.[6][7][8]
In 2022, USC President Dr.Carol Folt announced that most of AMI-USC's endowment will be reallocated to help support medical research and commercialization efforts of other entities within or affiliated with USC. These include theUSC School of Pharmacy,USC Viterbi School of EngineeringDepartment of Biomedical Engineering, andChildren's Hospital Los Angeles.
In 2023, AMI-USC was effectively dissolved by the USC administration. The institute's operations, management, staff, and volunteer Board of Directors were terminated after prior notification. Control over any remaining financial assets was transferred toUSC Research and Innovation (OORI).[9][10] AMI-USC no longer operates as an independent 501c(3) non-profit organization.
{{cite web}}: CS1 maint: multiple names: authors list (link)
